Answers are grounded in this paper and cite their sources.
Standardized interpretation of analytical responses in multi-herb formulations remains difficult: constituent measurements, composition ratios, and extraction conditions are rarely integrated quantitatively. Effect Factor (EF) provides a dimensionless, endpoint-aware index for matched-condition referencing, but constituent-level EF descriptors do not directly yield formulation-level expectations. Using an EF-indexed resource comprising 271 herbal materials and 22 multi-herb formulations with paired water and 30% ethanol extracts, we developed an EF-guided quantitative herbal medicine composition–activity relationship (QHMCAR) framework. Additive theoretical formulation EFs for 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), 2,2-diphenyl-1-picrylhydrazyl (DPPH), total phenolic content (TPC), and total flavonoid content (TFC) were derived from constituent EFs, composition ratios, and solvent-matched extraction yields. Analyses included predictor screening, least-squares calibration, additive-deviation analysis, diagnostics, fixed-form refitting, nested leave-one-prescription-identity-out (LOPO), and solvent sensitivity. Retained full-data models showed apparent R2 of 0.748–0.830; fully nested grouped LOPO yielded Q2 of 0.543–0.809. Against a grouped-LOPO untransformed linear baseline, transformation screening modestly improved DPPH prediction, matched ABTS, and yielded lower Q2 for TPC and TFC. Positive additive deviations were endpoint-dependent, most pronounced for ABTS; solvent-sensitivity analysis identified limited additional variation except for an ABTS-specific intercept shift. QHMCAR enables transparent formulation-level expectation, calibration, and internal validation without implying pharmacological synergy, therapeutic efficacy, or external predictive validity.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: